Kiluk, P.; Baran, A.; Kaminski, T.W.; Maciaszek, M.; Flisiak, I.
The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients. J. Clin. Med. 2019, 8, 2206.
https://doi.org/10.3390/jcm8122206
AMA Style
Kiluk P, Baran A, Kaminski TW, Maciaszek M, Flisiak I.
The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients. Journal of Clinical Medicine. 2019; 8(12):2206.
https://doi.org/10.3390/jcm8122206
Chicago/Turabian Style
Kiluk, Paulina, Anna Baran, Tomasz W. Kaminski, Magdalena Maciaszek, and Iwona Flisiak.
2019. "The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients" Journal of Clinical Medicine 8, no. 12: 2206.
https://doi.org/10.3390/jcm8122206
APA Style
Kiluk, P., Baran, A., Kaminski, T. W., Maciaszek, M., & Flisiak, I.
(2019). The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients. Journal of Clinical Medicine, 8(12), 2206.
https://doi.org/10.3390/jcm8122206